Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)

NCT07191873 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07191873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07191873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Placebo-controlled Single Center Trial for Tirzepatide in Idiopathic Intracranial Hypertension Trial (TIIHT)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Recruiting
Start date
August 25, 2026
Completion date
August 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic intracranial hypertension (iih)